Flash FinanceUS
Market closed S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · CTS (CTS)

CTS Q3 sales rose to $149.6 million; FY2026 adjusted EPS guided to $2.78-$2.88

Positive Impact 3 of 5 guidance

CTS Corporation furnished an October 2026 investor presentation under Regulation FD. It shows third-quarter 2026 net sales of $149.6 million, up from $143.0 million a year earlier, and GAAP diluted EPS of $0.61 versus $0.46. The deck also gives updated fiscal 2026 guidance of $580 million to $590 million in revenue and $2.78 to $2.88 in adjusted diluted EPS, with the Millar acquisition included.

Key points

  • Q3 2026 net sales were $149.6 million, compared with $143.0 million in Q3 2025.
  • Q3 2026 net earnings were $17.8 million, or $0.61 per diluted share, compared with $13.7 million, or $0.46, a year earlier; adjusted diluted EPS was $0.77 versus $0.60.
  • Updated FY 2026 guidance: revenue of $580 million to $590 million and adjusted diluted EPS of $2.78 to $2.88, including the expected impact of the Millar acquisition.
  • Q3 2026 results include a $12.5 million pretax insurance recovery, which the company excludes from adjusted figures.

The filing

CompanyCTS (CTS)
Form8-K, current report
Filed with the SECOct 27, 2026, 1:26 PM ET
Accession number0001193125-26-433580

Items reported: 7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 7, 2026, 11:17 PM ET, from this filing only.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.